Human Reproduction, Vol 13, 259-267, Copyright © 1998 by Oxford University Press
MB Zelinski-Wooten, OD Slayden, K Chwalisz, DL Hess, RM Brenner and RL Stouffer
Large doses of antiprogestin typically disrupt menstrual cyclicity. A
chronic low-dose regimen of the potent new antiprogestin ZK 137 316, which
permits continued menstrual cyclicity but alters gonadal- reproductive
tract activity, was established. Rhesus monkeys received vehicle (n = 6) or
0.01 (n = 8), 0.03 (n = 8) or 0.1 (n = 5) mg ZK 137 316/kg body weight
daily for five menstrual cycles (C-1 to C-5). Oestradiol, progesterone and
gonadotrophin profiles were normal during cycles involving vehicle and 0.01
and 0.03 mg ZK 137 316/kg body weight. In the 0.1 mg/kg group, mid-cycle
oestradiol and gonadotrophin surges, and subsequent progesterone
production, were absent in C-3 and C-5. Ovarian cyclicity was accompanied
by timely menstruation in the vehicle and 0.01 mg/kg groups. By C-3, half
the animals in the 0.03 mg/kg group and all animals in the 0.1 mg/kg group
were amenorrhoeic. A corpus luteum was noted during the mid-luteal phase of
C-5 in the vehicle, 0.01 mg/kg and 0.03 mg/kg groups. Large antral and
cystic follicles were evident in the 0.1 mg/kg group. Thus, a daily
treatment with 0.01 mg/kg ZK 136317 permitted normal menstrual cyclicity in
macaques. While the daily administration of 0.03 mg/kg ZK 136 317 allowed
ovarian cyclicity, menstruation was disrupted in some animals. Increasing
the dose to 0.1 mg/kg antagonized pituitary function and resulted in
anovulation and amenorrhoea. A chronic low-dose regimen of the
antiprogestin ZK 137 316, which permits normal ovarian/menstrual cyclicity,
has potential as a contraceptive in women.
ARTICLES
Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Beaverton 97006, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. L. Bogan, M. J. Murphy, and J. D. Hennebold Dynamic Changes in Gene Expression that Occur during the Period of Spontaneous Functional Regression in the Rhesus Macaque Corpus Luteum Endocrinology, March 1, 2009; 150(3): 1521 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Wright, T. Pejovic, J. Fanton, and R. L. Stouffer Induction of proliferation in the primate ovarian surface epithelium in vivo Hum. Reprod., January 1, 2008; 23(1): 129 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Chabbert-Buffet, G. Meduri, P. Bouchard, and I. M. Spitz Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications Hum. Reprod. Update, May 1, 2005; 11(3): 293 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.H. Shaamash and M.M. Zakhari Increased serum levels of nitric oxide metabolites among users: a possible role in progestin-induced bleeding Hum. Reprod., January 1, 2005; 20(1): 302 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.M. Borman, K.M. Schwinof, C. Niemeyer, K. Chwalisz, R.L. Stouffer, and M.B. Zelinski-Wooten Low-dose antiprogestin treatment prevents pregnancy in rhesus monkeys and is reversible after 1 year of treatment Hum. Reprod., January 1, 2003; 18(1): 69 - 76. [Abstract] [Full Text] [PDF]
|
|